Vioxx Newsletter Archive

September 10, 2010 Issue 86: What obstacles might one encounter in filing a Vioxx lawsuit?
September 3, 2010 Issue 85: How is the legal landscape going to change thanks to Vioxx?
August 27, 2010 Issue 84: What legal fallout is anticipated from Vioxx?
August 20, 2010 Issue 83: Will Vioxx be coming back on the market?
August 13, 2010 Issue 82: What changes are being made to recent studies regarding Vioxx side effects?
August 6, 2010 Issue 81: What was the role of Merck “detailers” in selling Vioxx?
July 30, 2010 Issue 80: Why is Merck facing allegations that it coveredup information about Vioxx side effects?
July 23, 2010 Issue 79: What is the medical literature saying about COX 2 inhibitors?
July 16, 2010 Issue 78: When was evidence of cardiovascular side effects of Vioxx first published?
July 9, 2010 Issue 77: How widely has Vioxx been distributed?
July 2, 2010 Issue 76: How many heart attacks might be attributable to Vioxx?
June 25, 2010 Issue 75: How was Merck's sales force instructed to talk to doctors?
June 18, 2010 Issue 74: How has Merck behaved in disclosing negative results about Vioxx?
June 11, 2010 Issue 73: What are we now learning about how drugs like Vioxx are marketed?
June 4, 2010 Issue 72: When was Vioxx first approved by the FDA?
May 28, 2010 Issue 71: How does Vioxx work?
May 21, 2010 Issue 70: Under what circumstances might I be entitled to compensation for damage from Vioxx?
May 14, 2010 Issue 69: What effect do state laws have on Vioxx lawsuits?
May 7, 2010 Issue 68: What is liability law and how does it work with respect to Vioxx?
April 30, 2010 Issue 67: What are the pros and cons of a Vioxx class action lawsuit?
April 23, 2010 Issue 66: Should I file an individual or class action Vioxx lawsuit?
April 16, 2010 Issue 65: What can I recover from a successful Vioxx class action lawsuit?
April 9, 2010 Issue 64: Will it become easier to find a Vioxx lawyer?
March 26, 2010 Issue 63: What steps is the FDA taking to impove public awareness of potential drug risks?
March 19, 2010 Issue 62: What is congress doing in response the the Vioxx affair?
March 12, 2010 Issue 61: Debate over Vioxx
March 5, 2010 Issue 60: Examining the FDA's Approval of Vioxx
February 26, 2010 Issue 59: What reforms are being suggested to prevent the FDA from approving dangerous drugs?
February 19, 2010 Issue 58: How should I prepare for a Vioxx lawsuit?
February 5, 2010 Issue 57: What are the criteria for Vioxx-related side effects that could bring compensation?
January 29, 2010 Issue 56: What are the supposed advantages of COX 2 inhibitors like Vioxx?
January 22, 2010 Issue 55: How many people have suffered from the side effects of Vioxx?
January 15, 2010 Issue 54: What role has the FDA approval process played in the Vioxx problems?
January 8, 2010 Issue 53: How did Merck first repond to early data regarding fatal side effects of Vioxx?
January 1, 2010 Issue 52: What instructions were given to Merck's salespeople for discussing Vioxx with doctors?
December 25, 2009 Issue 51: What is the statute of limitations for Vioxx lawsuits?
December 18, 2009 Issue 50: How has Merck responded to charges of coverup in the case of Vioxx?
December 11, 2009 Issue 49: Under what circumstances might Vioxx return to the market?
December 4, 2009 Issue 48: Are there Alternatives to Vioxx?
November 27, 2009 Issue 47: What Alternatives to Vioxx are Available?
September 28, 2007 Issue 46: What are the side effects of Vioxx?
September 21, 2007 Issue 45: Is Merck considering bringing Vioxx back to the market?
September 14, 2007 Issue 44: The Cost of Vioxx
September 7, 2007 Issue 43: When does liability law come into effect with Vioxx?
August 31, 2007 Issue 42: What information should I be collecting prior to a Vioxx lawsuit?
August 24, 2007 Issue 41: How have recent congressional hearings affected potential Vioxx lawsuits?
August 17, 2007 Issue 40: What obstacles might one encounter in filing a Vioxx lawsuit?
August 10, 2007 Issue 39: How is the legal landscape going to change thanks to Vioxx?
August 3, 2007 Issue 38: What legal fallout is anticipated from Vioxx?
July 27, 2007 Issue 37: Will Vioxx be coming back on the market?
July 13, 2007 Issue 36: What changes are being made to recent studies regarding Vioxx side effects?
July 6, 2007 Issue 35: What was the role of Merck “detailers” in selling Vioxx?
June 29, 2007 Issue 34: Why is Merck facing allegations that it coveredup information about Vioxx side effects?
June 22, 2007 Issue 33: What is the medical literature saying about COX 2 inhibitors?
June 15, 2007 Issue 32: When was evidence of cardiovascular side effects of Vioxx first published?
June 8, 2007 Issue 31: How widely has Vioxx been distributed?
June 1, 2007 Issue 30: How many heart attacks might be attributable to Vioxx?
September 8, 2006 Issue 29: How was Merck's sales force instructed to talk to doctors?
September 1, 2006 Issue 28: How has Merck behaved in disclosing negative results about Vioxx?
August 25, 2006 Issue 27: What are we now learning about how drugs like Vioxx are marketed?
August 18, 2006 Issue 26: When was Vioxx first approved by the FDA?
August 4, 2006 Issue 25: How does Vioxx work?
July 21, 2006 Issue 24: Under what circumstances might I be entitled to compensation for damage from Vioxx?
July 14, 2006 Issue 23: What effect do state laws have on Vioxx lawsuits?
July 7, 2006 Issue 22: What is liability law and how does it work with respect to Vioxx?
June 30, 2006 Issue 21: What are the pros and cons of a Vioxx class action lawsuit?
June 23, 2006 Issue 20: Should I file an individual or class action Vioxx lawsuit?
June 16, 2006 Issue 19: What can I recover from a successful Vioxx class action lawsuit?
June 9, 2006 Issue 18: Will it become easier to find a Vioxx lawyer?
May 26, 2006 Issue 17: What steps is the FDA taking to impove public awareness of potential drug risks?
May 19, 2006 Issue 16: What is congress doing in response the the Vioxx affair?
May 12, 2006 Issue 15: Debate over Vioxx
May 5, 2006 Issue 14: Examining the FDA's Approval of Vioxx
April 28, 2006 Issue 13: What reforms are being suggested to prevent the FDA from approving dangerous drugs?
April 21, 2006 Issue 12: How should I prepare for a Vioxx lawsuit?
April 14, 2006 Issue 11: What are the criteria for Vioxx-related side effects that could bring compensation?
April 7, 2006 Issue 10: What are the supposed advantages of COX 2 inhibitors like Vioxx?
March 31, 2006 Issue 9: How many people have suffered from the side effects of Vioxx?
March 17, 2006 Issue 8: What role has the FDA approval process played in the Vioxx problems?
March 10, 2006 Issue 7: How did Merck first repond to early data regarding fatal side effects of Vioxx?
March 3, 2006 Issue 6: What instructions were given to Merck's salespeople for discussing Vioxx with doctors?
February 24, 2006 Issue 5: What is the statute of limitations for Vioxx lawsuits?
February 17, 2006 Issue 4: How has Merck responded to charges of coverup in the case of Vioxx?
February 10, 2006 Issue 3: Under what circumstances might Vioxx return to the market?
February 3, 2006 Issue 2: Are there Alternatives to Vioxx?
January 27, 2006 Issue 1: What Alternatives to Vioxx are Available?
Not finding the advice and tips you need on this Vioxx Tip Site? Request a Tip Now!


Guru Spotlight
Mary White